A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin ...
... in combination with carboplatin + paclitaxel or carboplatin + nab-paclitaxel compared with treatment with carboplatin + nab- ... in Combination With Carboplatin+Paclitaxel or Atezolizumab in Combination With Carboplatin+Nab-Paclitaxel Versus Carboplatin+ ... Drug: Carboplatin Carboplatin area under the concentration curve (AUC) 6 milligrams per milliliter per minute (mg/mL/min) on ...https://clinicaltrials.gov/ct2/show/NCT02367794
Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse - Full Text View -...
Topotecan Plus Carboplatin im Vergleich Zur Standardtherapie (Paclitaxel Plus Carboplatin Oder Gemcitabin Plus Carboplatin) in ... the combination of carboplatin and paclitaxel as well as the combination of carboplatin with gemcitabine. Choice of therapy is ... Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse (HECTOR). This study has been ... Topotecan: 0,75 mg/m²/d, Tage 1-3 und Carboplatin: AUC 5 (after Cockroft and Gault formula) am Tag 3 nach Topotecan, q 21d. ...https://clinicaltrials.gov/show/NCT00437307
Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As 1st-Line Chemo - Ovarian...
Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy ... Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As 1st-Line Chemo - Ovarian ... every 4 weeks for six cycles or paclitaxel 175 mg/m2 plus carboplatin area under the curve 6.0 mg/mL/min on day 1 every 3 weeks ... with paclitaxel plus carboplatin (TC) in patients with CCC. ...https://ovariancancerandus.blogspot.com/2016/07/randomized-phase-iii-trial-of.html
Talazoparib, Carboplatin, and Paclitaxel in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by...
Giving talazoparib with carboplatin and paclitaxel may kill more tumor cells.. Condition or disease Intervention/treatment ... Drug: Carboplatin Other: Laboratory Biomarker Analysis Drug: Paclitaxel Other: Pharmacological Study Drug: Talazoparib Phase 1 ... No prior carboplatin unless given in neoadjuvant/adjuvant setting for curative intent and more than 6 months have elapsed since ... Talazoparib, Carboplatin, and Paclitaxel in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by ...https://clinicaltrials.gov/ct2/show/NCT02317874
Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer - Full Text...
I. To compare the response rate associated with the combination of vorinostat, carboplatin, paclitaxel versus carboplatin, ... Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. This study ... Drug: vorinostat Drug: paclitaxel Drug: carboplatin Other: placebo Other: laboratory biomarker analysis Phase 2 ... Carboplatin. Lung Neoplasms. Carcinoma, Non-Small-Cell Lung. Respiratory Tract Neoplasms. Thoracic Neoplasms. Neoplasms by Site ...https://clinicaltrials.gov/ct2/show/NCT00481078?term=Vorinostat+%26+Carboplatin+%26+Paclitaxel%3A+NSCLC&rank=3
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients...
ARM IV: Patients receive paclitaxel and ddAC as in Arm I, bevacizumab as in Arm II, and carboplatin as in Arm III. ... ARM III: Patients receive paclitaxel and ddAC as in Arm I. Patients also receive carboplatin IV over 30 minutes once in weeks 1 ... I. To assess whether the impact of the addition of carboplatin and/or bevacizumab to NAC with weekly paclitaxel followed by ... Patients receive paclitaxel and ddAC as in Arm I. Patients also receive carboplatin IV over 30 minutes once in weeks 1, 4, 7, ...https://clinicaltrials.gov/ct2/show/record/NCT00861705
Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer - Full Text View - ClinicalTrials.gov
Drug: gemcitabine and carboplatin Gemcitabine 1000mg/m2, DIV on day 1 and 15 of each 28 day cycle. Carboplatin AUC=3, DIV on ... Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer (GEEP). This study has been completed. ... Carboplatin. Antimetabolites, Antineoplastic. Antimetabolites. Molecular Mechanisms of Pharmacological Action. Antineoplastic ... Randomized Phase II Study of Biweekly Chemotherapy With Gemcitabine and Carboplatin in Elder Patients With Previously Untreated ...https://clinicaltrials.gov/show/NCT00881296
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer - Full Text View -...
Active Comparator: Carboplatin/Paclitaxel Chemotherapy. Drug: Carboplatin/Paclitaxel Paclitaxel 175 mg/m2 will administered ... Carboplatin AUC 5 will be administered intravenously every 21 days for 6 cycles. 100% of patients will receive Carboplatin/ ... Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer. This study is ongoing, ... Carboplatin AUC 5 will be administered intravenously every 21 days for 6 cycles. On day 1, an 8 mg/kg loading dose of ...https://clinicaltrials.gov/ct2/show/NCT01367002?recr=Open&cond=%22Endometrial+Neoplasms%22&rank=11
Effect of |em|BRCA1/2|/em| Status on Response to Neoadjuvant Carboplatin in Triple-Negative Breast Cancer - The ASCO Post
The pathologic complete response rate was 56.8% in the carboplatin group vs 41.4% in the group that did not receive carboplatin ... in the carboplatin group and 73.5% in the group that did not receive carboplatin (hazard ratio = 0.53, P = .04). ... The addition of carboplatin did not significantly increase pathologic complete response rate in patients with BRCA1/2 mutations ... Effect of BRCA1/2 Status on Response to Neoadjuvant Carboplatin in Triple-Negative Breast Cancer. By Matthew Stenger. Posted: 8 ...http://ascopost.com/News/57882
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With...
Drug: Carboplatin Carboplatin will be administered at area under the concentration-time curve (AUC) 6 milligrams per milliliter ... Drug: Carboplatin Carboplatin will be administered at area under the concentration-time curve (AUC) 6 milligrams per milliliter ... Drug: Carboplatin Carboplatin will be administered at area under the concentration-time curve (AUC) 6 milligrams per milliliter ... in combination with carboplatin+paclitaxel with or without bevacizumab compared with treatment with carboplatin+paclitaxel+ ...https://clinicaltrials.gov/ct2/show/NCT02366143?term=29436&rank=1
Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non...
Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non ... Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non ... It is not yet known whether paclitaxel and carboplatin is more effective than standard chemotherapy for advanced non-small cell ... Arm I: Patients receive paclitaxel IV over 3 hours, followed by carboplatin IV over 30 minutes on day 1. ...https://clinicaltrials.gov/ct2/show/record/NCT00004887
Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary - Full...
Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary. This ... Carboplatin will be administered on day 1, paclitaxel weekly for the first 3 weeks, and capecitabine twice daily on days 8 ... Carboplatin and paclitaxel will be given through intravenous infusions. Treatment drugs will be given on a four-week cycle. ... A Phase I Dose Escalation Study of Capecitabine, Carboplatin and Weekly Paclitaxel and a Phase II Trial of the Same Combination ...https://clinicaltrials.gov/show/NCT00201734
Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment - Full Text View - ClinicalTrials.gov
Experimental: Carboplatin Carboplatin will be prepared as a single 500ml infusion. Potentially 6 cycles Carboplatin (Amount of ... Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment. This study has been terminated. ... The change would be instead of carboplatin being administered over a 30 minute period, the carboplatin be administered ... For women with recurrent ovarian cancer, re-treatment with carboplatin is frequently recommended. However, carboplatin re- ...https://clinicaltrials.gov/ct2/show/NCT02035345?recr=Open&cond=%22Ovarian+Neoplasms%22&rank=8
Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer - Full Text View -...
Patients who have known carboplatin hypersensitivity reaction can receive carboplatin if they are followed by an allergist, ... Estimate the response rate of carboplatin/gemcitabine/vorinostat. *Assess the toxicities of carboplatin/gemcitabine/vorinostat ... Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer. The safety and scientific ... follow a published hypersensitivity desensitization protocol when receiving carboplatin, and agree to receive carboplatin under ...https://clinicaltrials.gov/ct2/show/NCT00910000?recr=Open&cond=%22Genital+Diseases%2C+Female%22&rank=15
Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer,...
Experimental: Treatment (bortezomib, carboplatin) Patients receive bortezomib IP and carboplatin IP on day 1. Treatment repeats ... Bortezomib may help carboplatin work better by making tumor cells more sensitive to the drug. Infusing bortezomib and ... Drug Information available for: Carboplatin Bortezomib Genetic and Rare Diseases Information Center resources: Ovarian Cancer ... Drugs used in chemotherapy, such as carboplatin, work in different ways to stop the growth of tumor cells, either by killing ...https://clinicaltrials.gov/ct2/show/NCT01074411?recr=Open&locn=%22hospital+of+central+connecticut%22&rank=8
A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer - Full Text View - ClinicalTrials.gov
Experimental: Carboplatin/Paclitaxel Carboplatin and paclitaxel alone.. Drug: Carboplatin 10mg/mL vial AUC6. Dosed ... Carboplatin and paclitaxel plus CDP791 10mg/kg. Drug: Carboplatin 10mg/mL vial AUC6. Dosed intravenously over 15-30 minutes ... Carboplatin and paclitaxel plus CDP791 20mg/kg. Drug: Carboplatin 10mg/mL vial AUC6. Dosed intravenously over 15-30 minutes ... Randomized/Comparing CDP791 Plus Carboplatin/Paclitaxel With Carboplatin/Paclitaxel Alone in Subjects With Locally Advanced or ...https://clinicaltrials.gov/ct2/show/NCT00152477
Navitoclax augments the activity of carboplatin and paclitaxel combinations in ovarian cancer cells | Read by QxMD
Antagonism between carboplatin and paclitaxel was evident in Ovcar-4, Ovcar-8 and Skov-3 cells. Drug combinations including ... Combinations of navitoclax, carboplatin and paclitaxel showed more than additive activity against Igrov-1 spheroids. ... A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients ... METHODS: 8 ovarian cancer cell lines were treated with either doublet or triplet combinations of navitoclax, carboplatin and ...https://www.readbyqxmd.com/read/23168176/navitoclax-augments-the-activity-of-carboplatin-and-paclitaxel-combinations-in-ovarian-cancer-cells
Carboplatin Aurobindo - Drugs.com
A list of US medications equivalent to Carboplatin Aurobindo is available on the Drugs.com website. ... Carboplatin Aurobindo is a medicine available in a number of countries worldwide. ... Ingredient matches for Carboplatin Aurobindo. Carboplatin. Carboplatin is reported as an ingredient of Carboplatin Aurobindo in ... Carboplatin Aurobindo. Carboplatin Aurobindo may be available in the countries listed below. ...https://www.drugs.com/international/carboplatin-aurobindo.html
Re: Re: [MOL] carboplatin 
Diane: My husband has adenocarcinoma (NSCLC) with a large tumor in the right lung and many many metatastic nodules in both lungs, hence surgery and radiation is not an option. Furthermore, he had pleural effusions which were drained once by thoracentesis and supposedly permanently by a talc poudrage procedure. As I mentioned he is taking the taxol/carbo and tolerating it fairly well, but I suspect it's not working (NSCLC in general does not respond to chemo as well as the more aggressive SCLC). Obviously, you have a different situation. Good luck. Keep me posted. Bess ------------------------------------------------------------------------ This is an automatically-generated notice. If you'd like to be removed from the mailing list, please visit the Medicine-On-Line Discussion Forum at ,http://www.meds.com/con_faq.html,, or send an email message to: email@example.com with the subject line blank and the body of the message containing the line: unsubscribe mol-cancer your-email-address where ...http://www.meds.com/archive/mol-cancer/1999/10/msg00331.html
Re: [MOL] Taxol, Carboplatin, Navelbine 
I went through 10 chemos (every week , , for 10 weeks) of taxol and carboplatin along with 34 radiation treatments to , , the ...http://www.meds.com/archive/mol-cancer/1999/01/msg02893.html
Carboplatin - Fresenius Kabi Ireland
Carboplatin Login required for. Carboplatin. Please note that due to the German Advertising in the Health Care System Act ( ...https://www.fresenius-kabi.com/ie/products/carboplatin
Carboplatin & etoposide - Information and support - Macmillan Cancer Support
If you or someone close to you has been diagnosed with cancer, you're not alone. Find out what to expect, get information, practical advice and support, hear from experts and read about other people's experiences.https://www.macmillan.org.uk/information-and-support/lung-cancer/small-cell-lung-cancer/treating/chemotherapy/drugs-and-combination-regimens/combination-chemotherapy/carboplatin-and-etoposide.html
Carboplatin Suppliers, all Quality Carboplatin Suppliers on Alibaba.com
Carboplatin Suppliers Directory - Find variety Carboplatin Suppliers, Manufacturers, Companies from around the World at , ... Carboplatin Anti-cancer Supplier , Carboplatin Factory Supplier , Pharmaceutical Carboplatin Supplier , Alpha Arbutin Supplier ... High Purity Carboplatin Supplier , High Purity Cas 41575-94-4 Carboplatin , High Quality Desloratadine Supplier , Cas 100643-71 ... Paclitaxel Carboplatin Supplier , Cas 41575-94-4 Supplier , Carboplatin Price Supplier , Glutathione Skin Whitening Injection ...https://www.alibaba.com/carboplatin-suppliers.html
Search of: Carboplatin AND BCL2 - List Results - ClinicalTrials.gov
Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer. * ... Whether concomitant carboplatin and etoposide administration alters oblimersen sodium steady state level ... Pharmacokinetic parameters of G3139 in combination with paclitaxel and carboplatin. *Disease response as having either ...https://clinicaltrials.gov/ct2/results?term=Carboplatin+AND+BCL2
Carboplatin | Chemotherapy | Living Beyond Breast Cancer
You may be offered carboplatin as part of a clinical trial. ... Carboplatin is a platinum-based type of chemotherapy. It may be ...http://www.lbbc.org/learn/treatments-and-research/chemotherapy/types-chemotherapy/carboplatin